201 related articles for article (PubMed ID: 35095581)
1. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Is Associated With Female Obsessive-Compulsive Disorder: An Updated Meta-Analysis of 2765 Obsessive-Compulsive Disorder Cases and 5558 Controls.
Shang Y; Wang N; Zhang E; Liu Q; Li H; Zhao X
Front Psychiatry; 2021; 12():685041. PubMed ID: 35095581
[No Abstract] [Full Text] [Related]
2. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
[TBL] [Abstract][Full Text] [Related]
3. Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Associated with Obsessive-Compulsive Disorder? A Meta-Analysis.
Wang S; Xu X; Yan P; Song M; Li J; Wang S
Psychiatr Danub; 2019 Jun; 31(2):141-147. PubMed ID: 31291217
[TBL] [Abstract][Full Text] [Related]
4. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
6. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
Katerberg H; Lochner C; Cath DC; de Jonge P; Bochdanovits Z; Moolman-Smook JC; Hemmings SM; Carey PD; Stein DJ; Sondervan D; Boer JA; van Balkom AJ; Polman A; Heutink P
Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1050-62. PubMed ID: 19219856
[TBL] [Abstract][Full Text] [Related]
7. No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.
Umehara H; Numata S; Kinoshita M; Watanabe S; Nakaaki S; Sumitani S; Ohmori T
Neuropsychiatr Dis Treat; 2016; 12():611-5. PubMed ID: 27042072
[TBL] [Abstract][Full Text] [Related]
8. Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.
Márquez L; Camarena B; Hernández S; Lóyzaga C; Vargas L; Nicolini H
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1600-5. PubMed ID: 23999029
[TBL] [Abstract][Full Text] [Related]
9. BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response.
Taj M J RJ; Ganesh S; Shukla T; Deolankar S; Nadella RK; Sen S; Purushottam M; Reddy YCJ; Jain S; Viswanath B
Asian J Psychiatr; 2018 Dec; 38():65-69. PubMed ID: 29079096
[TBL] [Abstract][Full Text] [Related]
10. Do obsessive-compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population.
Liu S; Cui J; Niu Z; Yi M; Zhang X; Che F; Ma X
World J Biol Psychiatry; 2015; 16(8):602-9. PubMed ID: 25771937
[TBL] [Abstract][Full Text] [Related]
11. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
[TBL] [Abstract][Full Text] [Related]
12. Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive-compulsive disorder.
Harika-Germaneau G; Langbour N; Patri S; Solinas M; Chatard A; Millet B; Hashemian F; Pérault-Pochat MC; Jaafari N; Lafay-Chebassier C
CNS Spectr; 2022 Oct; 27(5):645-651. PubMed ID: 34313207
[TBL] [Abstract][Full Text] [Related]
13. Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis.
Chen K; Wang N; Zhang J; Hong X; Xu H; Zhao X; Huang Q
Asia Pac Psychiatry; 2017 Jun; 9(2):. PubMed ID: 26687639
[TBL] [Abstract][Full Text] [Related]
14. BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients.
Abdolhosseinzadeh S; Alizadeh N; Shams J; Asadi S; Ahmadiani A
Exp Clin Psychopharmacol; 2020 Apr; 28(2):216-224. PubMed ID: 31180700
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).
Hemmings SM; Kinnear CJ; Van der Merwe L; Lochner C; Corfield VA; Moolman-Smook JC; Stein DJ
World J Biol Psychiatry; 2008; 9(2):126-34. PubMed ID: 17853300
[TBL] [Abstract][Full Text] [Related]
16. BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder.
Hemmings SM; Lochner C; van der Merwe L; Cath DC; Seedat S; Stein DJ
J Psychiatr Res; 2013 Dec; 47(12):1857-63. PubMed ID: 24050777
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
18. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.
Fullana MA; Alonso P; Gratacòs M; Jaurrieta N; Jiménez-Murcia S; Segalàs C; Real E; Estivill X; Menchón JM
Eur Psychiatry; 2012 Jul; 27(5):386-90. PubMed ID: 22153732
[TBL] [Abstract][Full Text] [Related]
19. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
Tükel R; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Direskeneli GS
J Clin Neurosci; 2014 May; 21(5):790-3. PubMed ID: 24291483
[TBL] [Abstract][Full Text] [Related]
20. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
